RxDoctor Payments Data

Adam Landsman, DPM

Foot Surgery · Boston, MANPI 1407854094

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.5%), consulting fees and royalties or licence payments — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Lifenet Health at 40.8% of the total. Among foot surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$384,938in general payments, 2019–2025

Across 304 payments — averaging $1266.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lifenet Health$157K
  • Misonix Inc$141K
  • Bioventus LLC$41K
  • Johnson & Johnson$20K
  • In2bones USA, LLC$8K
  • Crossroads Extremity Systems, LLC$8K
  • plus $10K from 21 others

What the payments were for

  • Royalty or licence$35,6569%
  • Consulting fees$114,02030%
  • Speaking & faculty fees$198,18951%
  • Travel & lodging$28,7017%
  • Food & beverage$7,5662%
  • Education$8060%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$384,938 in reported general payments places this provider in the 95th percentile of 41 foot surgery providers in Massachusetts.

See all foot surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$203,564
Medicare patients
559
Services billed
3,123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole32$48,668
Lidocaine30$2,997
Diclofenac Sodium46$1,095
Ammonium Lactate44$642
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip17$396
Pregabalin22$329
Terbinafine Hcl38$323
Doxycycline Monohydrate36$266
Econazole Nitrate11$265
Meloxicam92$223
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen31$202
Ciprofloxacin Hcl12$122
Oxycodone Hcl18$114
Cephalexin12$51
Tramadol Hcl12$51

Paid to pharmacies, not to this prescriber.

Other foot surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →